Epigenomics AG (ECX) - Product Pipeline Analysis

Epigenomics AG (ECX) - Product Pipeline Analysis

Aug 2012 GlobalData Market Guide35 Pages Price :
$ 750

Epigenomics AG (Epigenomics) is a molecular diagnostics company. It develops, manufactures and sells cancer screening tests and diagnostics. The company classifies its product line into three categories namely, Cancer Screening Tests, Cancer Specialty Diagnostics and Research Products. Its lead test development program is in colorectal cancer. The companys molecular diagnostic products are based on the methylation technology. The company\'s lead product is proColon, a blood-based test for rapid detection of colorectal cancer. Its product proColon is marketed in Europe and is under developmenatal stage for the US. The company has research and development partners with AstraZeneca, QIAGEN, Sysmex and Quest Diagnostics for the development of biomarkers that are predictive of drug response. Epigenomics is headquartered in Berlin, Germany.

This report is a source for data, analysis and actionable intelligence on the Epigenomics AG portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 3

Epigenomics AG - Business Description 4

Key Facts 5
Epigenomics AG - Major Products and Services 6
Epigenomics AG Pipeline Products by Equipment Type 7
Epigenomics AG Pipeline Products by Development Stage 9
Epigenomics AG Pipeline Products by Therapy Area 11
Epigenomics AG Pipeline Products by Trial Phase 13
Epigenomics AG Pipeline Products by Milestone Summary 15
Epi proColon 1.0 17
Epi proColon 1.0 Product Status 17
Epi proColon 1.0 Product Description 17
Epi proColon 1.0 Product Milestone 17
Epi proColon 1.0 Clinical Trial 19
Epi proColon 1.0 Product Patent Details 20
Epi proColon 2.0 23
Epi proColon 2.0 Product Status 23
Epi proColon 2.0 Product Description 23
Epi proColon 2.0 Product Milestone 24
Epi proLung BL 1.0 - Blood Plasma 25
Epi proLung BL 1.0 - Blood Plasma Product Status 25
Epi proLung BL 1.0 - Blood Plasma Product Description 25
Epi proLung BL 1.0 - Blood Plasma Product Milestone 25
Epi proLung BL 1.0 - Blood Plasma Clinical Trial 26
Epigenomics AG - Key Competitors 27
Epigenomics AG - Key Employees 28
Epigenomics AG - Key Employee Biographies 29
Epigenomics AG - Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Epigenomics AG, Recent Developments 31
May 09, 2012: Epigenomics Reports Q1 2012 Results 31
Jan 04, 2012: Epigenomics Announces Initiation Of PMA Filing For Epi proColon, Provides Update On Regulatory Timeline 31
Nov 09, 2011: Epigenomics Reports Q3 2011 Results 32
Jul 07, 2011: Surveys Show That Patients Believe In Blood Tests For Regular Colorectal Cancer Screening: Epigenomics 32
Apr 20, 2011: Epigenomics Appoints Noel Doheny As New CEO For US-Subsidiary 33
Apr 07, 2011: Epigenomics Reports Revenue Of 1.8m In 2010 33
Jan 11, 2011: Epigenomics Appoints Thomas Taapken As New CFO 34

Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Table


Epigenomics AG, Key Facts 1
Epigenomics AG Key Pipeline Products by Equipment Type 1
Epigenomics AG Key Pipeline Products by Therapy Area 1
Epigenomics AG Key Pipeline Products by Development Stage 1
Epigenomics AG Key Pipeline Products by Trial Phase 1
Epigenomics AG, Key Facts 5
Epigenomics AG, Major Products and Services 6
Epigenomics AG Number of Pipeline Products by Equipment Type 7
Epigenomics AG Pipeline Products by Equipment Type 8
Epigenomics AG Number of Pipeline Products by Development Stage 9
Epigenomics AG Pipeline Products by Development Stage 10
Epigenomics AG Number of Pipeline Products by Therapy Area 11
Epigenomics AG Pipeline Products by Therapy Area 12
Epigenomics AG Number of Pipeline Products by Trial Phase 13
Epigenomics AG Pipeline Products by Trial Phase 14
Epigenomics AG Number of Pipeline Products By Milestone Summary 15
Epigenomics AG Pipeline Products by Milestone Summary 16
Epi proColon 1.0 - Product Status 17
Epi proColon 1.0 - Product Description 17
Epi proColon 1.0 - Product Milestone 17
Epi proColon 1.0 - PRESEPT Study: Prospective Evaluation of Septin 9 Performance for Colorectal Cancer Screening 19
Epi proColon 1.0 - Patent Details1 20
Epi proColon 1.0 - Patent Details2 20
Epi proColon 1.0 - Patent Details3 21
Epi proColon 1.0 - Patent Details4 21
Epi proColon 1.0 - Patent Details5 22
Epi proColon 1.0 - Patent Details6 22
Epi proColon 2.0 - Product Status 23
Epi proColon 2.0 - Product Description 23
Epi proColon 2.0 - Product Milestone 24
Epi proLung BL 1.0 - Blood Plasma - Product Status 25
Epi proLung BL 1.0 - Blood Plasma - Product Description 25
Epi proLung BL 1.0 - Blood Plasma - Product Milestone 25
Epi proLung BL 1.0 - Blood Plasma - Clinical Study Results In Lung Cancer Program 26
Epigenomics AG, Key Employees 28
Epigenomics AG, Key Employee Biographies 29
Epigenomics AG, Subsidiaries 30

List of Chart


Epigenomics AG Pipeline Products by Equipment Type 7
Epigenomics AG Pipeline Products by Development Stage 9
Epigenomics AG Pipeline Products by Therapy Area 11
Epigenomics AG Pipeline Products by Trial Phase 13
Epigenomics AG Pipeline Products by Milestone Summary 15

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 750
$ 1500

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top